CLINICAL TRIAL AGREEMENT FOR SYNTHETIC BIOLOGICS, INC.Clinical Trial Agreement • August 8th, 2019 • Synthetic Biologics, Inc. • Pharmaceutical preparations
THIS CLINICAL TRIAL AGREEMENT (the “Agreement”), effective this 7th day of August, 2019 (the “Effective Date”), is made by and between Synthetic Biologics, Inc., a Nevada corporation, having a place of business at 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850 (“Sponsor”) and Washington University, having a place of business at 660 S. Euclid Avenue, St. Louis, MO 63110 (“Institution”). Sponsor and Institution are sometimes individually referred to herein singly as a “Party” and collectively as the “Parties.”
